Annual ROE
637.82%
+895.44%+347.58%
December 31, 2023
Summary
- As of March 3, 2025, QLGN annual return on equity is 637.82%, with the most recent change of +895.44% (+347.58%) on December 31, 2023.
- During the last 3 years, QLGN annual ROE has risen by +876.67% (+367.04%).
- QLGN annual ROE is now at all-time high.
Performance
QLGN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
260.83%
-75.84%-22.53%
September 30, 2024
Summary
- As of March 3, 2025, QLGN quarterly return on equity is 260.83%, with the most recent change of -75.84% (-22.53%) on September 30, 2024.
- Over the past year, QLGN quarterly ROE has stayed the same.
- QLGN quarterly ROE is now -70.60% below its all-time high of 887.17%, reached on March 31, 2024.
Performance
QLGN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
QLGN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +347.6% | 0.0% |
| 3 y3 years | +367.0% | 0.0% |
| 5 y5 years | - | 0.0% |
QLGN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +347.6% | -70.6% | +115.3% |
| 5 y | 5-year | at high | +347.6% | -70.6% | +100.5% |
| alltime | all time | at high | +347.6% | -70.6% | +100.5% |
Qualigen Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 260.83%(-22.5%) |
| Jun 2024 | - | 336.67%(-62.1%) |
| Mar 2024 | - | 887.17%(-152.2%) |
| Dec 2023 | 637.82%(-347.6%) | -1698.74%(+206.1%) |
| Sep 2023 | - | -554.91%(+108.3%) |
| Jun 2023 | - | -266.38%(+42.0%) |
| Mar 2023 | - | -187.63%(+19.2%) |
| Dec 2022 | -257.62% | -157.38%(+35.3%) |
| Sep 2022 | - | -116.30%(+6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -109.54%(-10.4%) |
| Mar 2022 | - | -122.26%(-20.6%) |
| Dec 2021 | -102.68%(-57.0%) | -153.99%(-64.5%) |
| Sep 2021 | - | -433.99%(-62.2%) |
| Jun 2021 | - | -1148.93%(-97.6%) |
| Mar 2021 | - | -48.77 K%(<-9900.0%) |
| Dec 2020 | -238.85% | - |
| Sep 2020 | - | 332.79%(+131.2%) |
| Jun 2020 | - | 143.96% |
FAQ
- What is Qualigen Therapeutics annual return on equity?
- What is the all time high annual ROE for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual ROE year-on-year change?
- What is Qualigen Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly ROE year-on-year change?
What is Qualigen Therapeutics annual return on equity?
The current annual ROE of QLGN is 637.82%
What is the all time high annual ROE for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual return on equity is 637.82%
What is Qualigen Therapeutics annual ROE year-on-year change?
Over the past year, QLGN annual return on equity has changed by +895.44% (+347.58%)
What is Qualigen Therapeutics quarterly return on equity?
The current quarterly ROE of QLGN is 260.83%
What is the all time high quarterly ROE for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly return on equity is 887.17%
What is Qualigen Therapeutics quarterly ROE year-on-year change?
Over the past year, QLGN quarterly return on equity has changed by 0.00% (0.00%)